HemoShear Therapeutics is a company discovering treatments for rare metabolic disorders in children. Its technology helps to recapitulate diseases using tissue from livers of children born with genetic defects, interrogate the disrupted biochemical processes, explore drug intervention strategies, and select drug candidates with high probabilities of clinical success.
|HQ||Charlottesville, VA, US||Map|
|Employees (est.) (Jul 2021)||52||(+2%)|
HemoShear total Funding
HemoShear latest funding size
Time since last funding
|6 months ago|
|Janus Henderson Investors, Adage Capital Management LP, Suvretta Capital|
HemoShear has 391 Twitter Followers. The number of followers has increased 0.1% month over month and increased 0.2% quarter over quarter
When was HemoShear founded?
HemoShear was founded in 2008.
Who are HemoShear key executives?
HemoShear's key executives are James Powers, Brian Wamhoff and Brian A. Johns.
How many employees does HemoShear have?
HemoShear has 52 employees.
Who are HemoShear competitors?
Competitors of HemoShear include Beacon Discovery, Circle Pharma and Scioto Biosciences.
Where is HemoShear headquarters?
HemoShear headquarters is located at 501 Locust Ave #301, Charlottesville.
Where are HemoShear offices?
HemoShear has an office in Charlottesville.
How many offices does HemoShear have?
HemoShear has 1 office.
Receive alerts for 300+ data fields across thousands of companies